Related Experiment Video
Updated: Feb 20, 2026
14:39
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
32.6K
Endobronchial thermoplasty for asthma.
Felix Zamora1, Roy Cho1, Madhuri Rao2
1Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, University of Minnesota, Minneapolis, MN, USA.
Journal of Visualized Surgery
|October 29, 2017
Summary
Bronchial thermoplasty (BT) is an innovative procedure for severe asthma that reduces airway smooth muscle. This treatment aims to decrease airway hyperresponsiveness, leading to fewer exacerbations and improved quality of life for patients.
Area of Science:
- Pulmonary Medicine
- Medical Devices
- Respiratory Diseases
Background:
- Asthma is a chronic respiratory disease affecting millions, characterized by airway inflammation and hyperresponsiveness.
- Despite pharmacologic advancements, a subset of asthma patients remains unresponsive to traditional treatments.
- Airway smooth muscle (ASM) hypertrophy is a key factor in asthma pathology, contributing to bronchoconstriction and hyperresponsiveness.
Purpose of the Study:
- To introduce Bronchial Thermoplasty (BT) as an innovative therapeutic option for severe asthma.
- To investigate the potential of reducing ASM bulk to alleviate asthma symptoms and improve patient outcomes.
- To explore how BT can decrease healthcare costs associated with asthma exacerbations.
Main Methods:
- Bronchial thermoplasty (BT) procedure.
- Targeting and reduction of airway smooth muscle (ASM) mass.
- Assessment of changes in airway hyperresponsiveness and clinical symptoms post-procedure.
Main Results:
- Bronchial thermoplasty effectively reduces airway smooth muscle bulk.
- Reduction in ASM mass leads to decreased airway hyperresponsiveness and bronchoconstriction.
- Patients undergoing BT experience reduced exacerbations and improved quality of life.
Conclusions:
- Bronchial thermoplasty is a promising treatment for severe asthma, particularly in patients refractory to pharmacologic therapy.
- By reducing ASM, BT offers a novel approach to managing asthma, improving patient well-being.
- BT has the potential to decrease the economic burden of asthma on the healthcare system.
Related Concept Videos
01:26COPD: Management Using Bronchodilators and Corticosteroids
874
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
874
01:24Chest Physiotherapy
2.0K
Chest Physiotherapy (CPT) is a therapeutic technique used in respiratory care to improve ventilation, clear bronchial secretions, and enhance the efficiency of respiratory muscles. This therapy includes three primary procedures: postural drainage, percussion, and vibration. It can be performed on spontaneously breathing patients and those who are intubated and mechanically ventilated.
Purpose
CPT is primarily used for patients with excessive bronchial secretions who have difficulty clearing...
Purpose
CPT is primarily used for patients with excessive bronchial secretions who have difficulty clearing...
2.0K
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
1.8K
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
1.8K
01:17Drugs Used in Lower Respiratory Disorders: Overview
1.2K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.2K
01:30Asthma-IV: Diagnostic and Management
3.2K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.2K
01:23Inhaled Medications
868
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
868